-
InstaBlue Protein Stain Solution Protocol
2026-08-25
InstaBlue Protein Stain Solution addresses slow polyacrylamide gel staining by providing a ready-to-use Coomassie Brilliant Blue protein stain that can produce visible protein-dye complexes within 5 minutes without fixation, washing, or destaining. It is intended for protein electrophoresis analysis and downstream-compatible gel visualization, but it should not be treated as a universally validated standalone protein quantification assay or a substitute for laboratory-specific method validation.
-
Berberrubine chloride: Cancer Research Workflows
2026-08-24
Berberrubine chloride supports target-driven colorectal cancer research, combination studies in NSCLC, and exploratory urate-metabolism models. This workflow-focused guide covers salt handling, concentration selection, mechanistic validation, and troubleshooting for more reproducible experiments.
-
Mubritinib (TAK 165): A Phenotype-First Guide
2026-08-23
Mubritinib and TAK 165 are best understood as phenotype-first tools for dissecting complex I dependence, selective tumor vulnerability, and antiviral activity. This guide connects mitochondrial mechanism to assay design while clarifying what the monkeypox study does—and does not—establish.
-
Capsaicin: A Dual-Target Research Strategy
2026-08-22
Capsaicin is more than a TRPV1 agonist: it also provides a mechanistically defined route to study reversible KDM1A/LSD1 inhibition. This article connects channel pharmacology, epigenetic assays, and gastric cancer phenotypes into a practical framework for selecting controls and interpreting results.
-
HLY78: Practical Wnt/β-Catenin Assay Design
2026-08-21
Learn how HLY78 (SKU C5433) can support controlled Wnt/β-catenin pathway experiments while preventing common viability-assay misinterpretations. This scenario-based guide covers mechanism, assay compatibility, stock preparation, data analysis, and practical vendor selection.
-
TRPV1/TRPA1 Control of TSLP in Nasal Epithelium
2026-08-21
The reference study shows that TRPV1 and TRPA1 are functionally expressed in nasal epithelial cells and connect environmental sensing to TSLP production through calcium-dependent NFAT signaling. Its combined imaging, pharmacological, genetic, and chelation experiments provide a useful framework for investigating epithelial contributions to upper-airway inflammation.
-
SAR131675: A Causal Map of VEGFR-3 Biology
2026-08-20
SAR131675 is a selective VEGFR-3 inhibitor for dissecting lymphangiogenesis, angiogenesis, and VEGFC-dependent liver inflammation. This article translates its pharmacology into a causal assay strategy informed by a recent hepatic fibrosis study.
-
HyperFluor 488 Goat Anti-Mouse IgG for NET Imaging
2026-08-20
Build sensitive, cross-platform assays for psoriasis-related NETosis and IL-36R signaling with one affinity-purified fluorescent secondary. The same reagent can connect microscopy, flow cytometry, and western blot validation while keeping assay controls and tissue-background risks visible.
-
Recombinant Mouse IFN-γ in MASH-HCC Assays
2026-08-19
Use Recombinant Mouse IFN-γ as a controlled immune-pressure variable in bile acid, MHC-I, and tumor-cell antigenicity experiments. This workflow separates cytokine responsiveness from the GPR120–bile acid–NLRC5 mechanism and adds practical controls for reproducible immunometabolic research.
-
AI-10-49: A Target-Engagement Guide for inv(16) AML
2026-08-18
AI-10-49 is a CBFβ-SMMHC inhibitor that enables a layered approach to inv(16) acute myeloid leukemia research. This guide connects target engagement, RUNX1 chromatin redistribution, transcriptional recovery, and leukemia phenotypes to practical assay decisions.
-
iRhom2 in Olfaction: Receptor Regulation and Adaptation
2026-08-18
Azzopardi and colleagues identify iRhom2 as a previously underrecognized regulator in olfactory sensory neurons and link it to odorant receptor expression and activity-dependent adaptation through the ADAM17 pathway. The study combines mouse genetics, transcriptomics, in situ analysis, and a receptor activation model to propose a feedback mechanism in which odor exposure suppresses iRhom2 expression.
-
A-1331852: Interpreting BCL-XL Dependence
2026-08-17
A-1331852 is a selective BCL-XL inhibitor for dissecting apoptosis, chemotherapy-induced senescence, and BCL-2 family protein inhibition. This guide focuses on experimental interpretation: how to distinguish target engagement from genuine BCL-XL dependence and design more informative apoptosis assays.
-
Erastin and the Timing of Ferroptotic Stress
2026-08-17
Erastin offers a mechanistic route to study ferroptosis in RAS- and BRAF-altered tumor models. This thought-leadership guide connects cystine–glutathione failure with time-resolved oxidative-stress biology and translational experimental design.
-
Mubritinib (TAK 165): A Metabolic Translation Playbook
2026-08-16
Mubritinib is best understood not as a conventional HER2 agent, but as a context-selective mitochondrial complex I inhibitor. This thought-leadership guide connects its AML and KSHV-positive PEL activity with assay design, formulation-aware translation, and a more disciplined strategy for cancer biology research.
-
CD38 CAR Binder Structures and Affinity Tuning
2026-08-15
Cheng et al. structurally compared the CD38-targeting CAR binders RP02 and 028, showing that distinct epitope geometries govern antigen recognition, enzymatic inhibition, and cellular behavior. Their affinity-attenuated 028R103G design reduced CAR-T fratricide while preserving cytotoxicity, supporting structure-guided optimization rather than maximal-affinity selection.